Recite me link

Question 1
Within the last 2 years, has the institution accepted or is it currently accepting any of the following drugs free of charge or for a nominal charge (eg £1):
Risankizumab (Skyrizi)
Guselkumab (Tremfya)
Brodalumab (Kyntheum)
Ixekizumab (Taltz)
Secukinumab (Cosentyx)
Tildrakizumab (Ilumetri)
Question 2
If yes to any of the above, are you able to say how long is the free of charge drug stock typically provided for each patient? For example, is it:
First dose
First month
First 3 months
Some other period?
Question 3
If the Institution has not accepted manufacturer provision of free of charge drug stock, are you able to say what have been the reasons for this?

Download response Drugs free of charge or for a nominal charge. 310720